Page 95 - Sohini Das

Covid-19 vaccine: Bharat Biotech to use Kansas firm's adjuvant for Covaxin

Adjuvants may be added to a vaccine to produce more antibodies and longer lasting immunity thus minimising the dose of antigen needed

Sales of Biocon's itolizumab surge as phase-4 clinical trials begin

With phase 4 clinical trials now on, the sales may see a further uptick if data supports its use on Covid-19 patients, said experts.

Indigenous players on a slow and steady coronavirus vaccine race

Smaller players are bullish on playing crucial role in nation's vaccine infrastructure

Patented molecules clock a high growth rate in Indian cardiovascular market

In January 2020, the Delhi High Court granted an injunction restraining domestic companies such as Cipla, Torrent, Emcure, and Alkem from launching their brands

Covid-19: 8% super-spreaders account for 60% new infections, says study

The findings are part of a survey conducted by the Center For Disease Dynamics, Economics & Policy (CDDEP) along with governments of Tamil Nadu and Andhra Pradesh

Revised, more industry-friendly PLI scheme for bulk drugs on the cards

Industry says move will mean lower spends and reduced dependence on China

Covid-19: Dr Reddy's to distribute Russian vaccine in India. What we know

While Dr Reddy's Labs is preparing for clinical trials of Sputnik V, major manufacturers in the country are sceptical about the drug

Covid-19: Mass production of Sputnik V likely to take several months

Vaccine makers here feel the Sputnik is still a work in progress and needs time to develop

Russian vaccine on its way to India, pact signed with Dr Reddy's for trials

Talks are also on with five major Indian manufacturers here to produce the vaccine for India and the world

Festival spook: Covid-19 cases surge in Mumbai post Ganpati celebrations

Upcoming festival season is likely to push up Covid-19 numbers across the country

Spike in Covid-19 cases bares gaps in Delhi, Mumbai critical care infra

Industry says govt makeshift facilities lie vacant as patients scramble for private hospital beds

Serum Institute of India gets nod to resume Covid-19 vaccine trial

The resumption of trails was allowed after the vaccine maker submitted recommendations of the Data Safety Monitoring Board (DSMB), the UK, and DSMB, India

Aurobindo gears up for multiple Covid-19 vaccines, ties up with CSIR

Developing own candidate; to develop and make CSIR vaccine candiates

NPPA extends price cap on knee implants by a year to September 2021

A few weeks back, the pricing regulator had extended the price cap by a month after the earlier order validity ended in August

Paracetamol curbs amid Covid-19 pandemic dent sales during monsoon

Sales of paracetamol are typically high during monsoon when cold and flu ailments are common

AstraZeneca resumes clinical trials in UK after green signal

Meanwhile, DCGI asks Serum Institute to submit DSMB UK and India data to resume trials, after asking it to stop recruiting volunteers on Friday

Bharat Biotech's Covaxin succeeds in challenge trials on Rhesus monkeys

The results showed protective efficacacy, increasing Sars-CoV-2 specific IgG and neutralising antibodies reducing the replication of the virus in the nasal cavity, throat and lung tissues of monkey

Kochi firm gets nod to test India's first novel molecule for Covid-19

PNB Vesper's drug developed from 12 years of research for small-cell lung cancer (for which it is under trial) has shown positive response in Covid-19, the firm claims

Innovative therapy for coronavirus is required as much as a vaccine

Pharma giants have already started work on different formulations and combination therapies of their existing molecules

Unlock 4.0: User industries turn to innovations as economy opens up further

A gamechanger for offices and factories in the country, the Shycocan, which can clear an area of 1000 square feet from coronaviruses, was discovered by accident